John H. Mcdermott

49 Benson Road
Te Awamutu, WKO 3800, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

MT-RNR1 genotype testing for preventing aminoglycoside-mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

MT-RNR1 genotype testing for preventing aminoglycoside-mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

Journal: British journal of clinical pharmacology

Published: June 25, 2026

Pharmacogenomics to Improve Supportive Care Symptoms. A Prospective Observational Study Protocol.

Pharmacogenomics to Improve Supportive Care Symptoms. A Prospective Observational Study Protocol.

Journal: NIHR open research

Published: March 25, 2026

Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study.

Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study.

Journal: The pharmacogenomics journal

Published: March 13, 2026

Implementing pharmacogenetic-guided prescribing in general practice: a qualitative process evaluation.

Implementing pharmacogenetic-guided prescribing in general practice: a qualitative process evaluation.

Journal: Implementation science communications

Published: January 16, 2026

From evidence to implementation: key priorities for pharmacogenomics-guided treatment and prevention from a European expert workshop.

From evidence to implementation: key priorities for pharmacogenomics-guided treatment and prevention from a European expert workshop.

Journal: European journal of human genetics : EJHG

Published: January 08, 2026

From science to service-overcoming clinical implementation barriers to population genomic screening.

From science to service-overcoming clinical implementation barriers to population genomic screening.

Journal: European journal of human genetics : EJHG

Published: December 11, 2025

Development and validation of an open data model for pharmacogenetics to enable semantic interoperability in clinical practice.

Development and validation of an open data model for pharmacogenetics to enable semantic interoperability in clinical practice.

Journal: The pharmacogenomics journal

Published: December 10, 2025

Consistency and clarity of pharmacogenomic guidance in UK medicine patient information leaflets: A cross-sectional analysis.

Consistency and clarity of pharmacogenomic guidance in UK medicine patient information leaflets: A cross-sectional analysis.

Journal: British journal of clinical pharmacology

Published: November 27, 2025

Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort.

Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort.

Journal: Clinical and translational science

Published: November 11, 2025

How to implement pre-emptive pharmacogenetic testing in the acute hospital setting.

How to implement pre-emptive pharmacogenetic testing in the acute hospital setting.

Journal: Pharmacogenomics

Published: September 19, 2025

Open-Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women.

Open-Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women.

Journal: Clinical and translational science

Published: August 26, 2025

Using Genomic Data in Clinical Decision Making: The Opportunities and Challenges.

Using Genomic Data in Clinical Decision Making: The Opportunities and Challenges.

Journal: British journal of hospital medicine (London, England : 2005)

Published: August 23, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026